Role of gut microbiota in graft-versus-host disease

Leukemia and Lymphoma

Volumn 52, Issue 10, 2011, Pages 1844-1856

  Murphy, Stephen ^a   Nguyen, Vu H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

graft versus host disease; Microbiota

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

BACTEROIDETES; BIFIDOBACTERIUM; CANDIDA; CLOSTRIDIUM; COLIFORM BACTERIUM; COLON; DISEASE MODEL; DUODENUM; ENTERITIS; EXPERIMENTAL MOUSE; FIRMICUTES; GRAFT VERSUS HOST REACTION; HELICOBACTER PYLORI; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOST PARASITE INTERACTION; HUMAN; ILEUM; INNATE IMMUNITY; INTESTINE FLORA; LACTOBACILLUS; MICROBIOME; NONHUMAN; PEPTOSTREPTOCOCCUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STOMACH; STREPTOCOCCUS;

GASTROINTESTINAL TRACT; GRAFT VS HOST DISEASE; HUMANS; IMMUNITY, INNATE; METAGENOME;

EID: 80053214198     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.580476     Document Type: Review

References (119)

1. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 2009;373:1550-1561.
2. Paczesny S, Hanauer D, Sun Y, Reddy P. New perspectives on the biology of acute GVHD. Bone Marrow Transplant 2010;45:1-11.
3. van Bekkum DW, Knaan S. Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction. J Natl Cancer Inst 1977;58:787-790. (Pubitemid 8056498)
4. van Bekkum DW, Roodenburg J, Heidt PJ, van der Waaij D. Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora. J Natl Cancer Inst 1974;52:401-404.
5. Jones JM, Wilson R, Bealmear PM. Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiat Res 1971;45:577-588.
6. Heit H, Heit W, Kohne E, Fliedner TM, Hughes P. Allogeneic bone marrow transplantation in conventional mice: I. Effect of antibiotic therapy on long term survival of allogeneic chimeras. Blut 1977;35:143-153. (Pubitemid 8163861)
7. Heidt PJ, Vossen JM. Experimental and clinical gnotobiotics: influence of the microflora on graft-versus-host disease after allogeneic bone marrow transplantation. J Med 1992;23: 161-173.
8. Beelen DW, Elmaagacli A, Müller KD, Hirche H, Schaefer UW. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an openlabel prospective randomized trial. Blood 1999;93:3267-3275. (Pubitemid 29220893)
9. Vossen JM, Heidt PJ, van den Berg H, Gerritsen EJ, Hermans J, Dooren LJ. Prevention of infection and graftversus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur J Clin Microbiol Infect Dis 1990;9:14-23. (Pubitemid 20046730)
10. Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol 2007;7:340-352. (Pubitemid 46674485)
11. Holler E, Landfried K, Meier J, Hausmann M, Rogler G. The role of bacteria and pattern recognition receptors in GVHD. Int J Inflam 2010;2010:814326.
12. Shlomchik WD, Couzens MS, Tang CB, et al. Prevention of graft versus host disease by inactivation of host antigenpresenting cells. Science 1999;285:412-415. (Pubitemid 29343964)
13. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
14. Salzman NH, de Jong H, Paterson Y, Harmsen HJ, Welling GW, Bos NA. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 2002;148:3651-3660. (Pubitemid 35414474)
15. Bjö rkstén B, Sepp E, Julge K, Voor T, Mikelsaar M. Allergy development and the intestinal microflora during the first year of life. J Allergy Clin Immunol 2001;108:516-520. (Pubitemid 32978019)
16. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-519. (Pubitemid 36173720)
17. Sears CL. A dynamic partnership: celebrating our gut flora. Anaerobe 2005;11:247-251. (Pubitemid 41138226)
18. Steinhoff U. Who controls the crowd? New findings and old questions about the intestinal microflora. Immunol Lett 2005;99:12-16. (Pubitemid 40718927)
19. Fanaro S, Chierici R, Guerrini P, Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 2003;91:48-55. (Pubitemid 37239252)
20. Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R, Busscher HJ. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol 2011;9:27-38.
21. Schwiertz A, Gruhl B, Lö bnitz M, Michel P, Radke M, Blaut M. Development of the intestinal bacterial composition in hospitalized preterm infants in comparison with breast-fed, full-term infants. Pediatr Res 2003;54:393-399. (Pubitemid 37013203)
22. Mackie RI, Sghir A, Gaskins HR. Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutr 1999;69:1035S-1045S. (Pubitemid 29205082)
23. Favier CF, Vaughan EE, De Vos WM, Akkermans AD. Molecular monitoring of succession of bacterial communities in human neonates. Appl Environ Microbiol 2002;68:219-226. (Pubitemid 34031183)
24. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007;5:e177.
25. Jiang HQ, Bos NA, Cebra JJ. Timing, localization, and persistence of colonization by segmented filamentous bacteria in the neonatal mouse gut depend on immune status of mothers and pups. Infect Immun 2001;69:3611-3617. (Pubitemid 32493275)
26. Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr 1999;69:1046S-1051S. (Pubitemid 29205083)
27. Khoury KA, Floch MH, Hersh T. Small intestinal mucosal cell proliferation and bacterial flora in the conventionalization of the germfree mouse. J Exp Med 1969;130:659-670.
28. Savage DC, Siegel JE, Snellen JE, Whitt DD. Transit time of epithelial cells in the small intestines of germfree mice and ex-germfree mice associated with indigenous microorganisms. Appl Environ Microbiol 1981;42:996-1001.
29. Shi HN, Walker A. Bacterial colonization and the development of intestinal defences. Can J Gastroenterol 2004;18: 493-500. (Pubitemid 39248249)
30. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002;99:15451-15455. (Pubitemid 35403955)
31. Mariadason JM, Nicholas C, L'Italien KE, et al. Gene expression profiling of intestinal epithelial cell maturation along the crypt-villus axis. Gastroenterology 2005;128:1081-1088. (Pubitemid 40523558)
32. Ivanov II, Littman DR. Modulation of immune homeostasis by commensal bacteria. Curr Opin Microbiol 2011;14:106-114.
33. Sharma R, Young C, Neu J. Molecular modulation of intestinal epithelial barrier: contribution of microbiota. J Biomed Biotechnol 2010;2010:305879.
34. Fukata M, Vamadevan AS, Abreu MT. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. Semin Immunol 2009;21:242-253.
35. Duffner UA, Maeda Y, Cooke KR, et al. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol 2004;172:7393-7398. (Pubitemid 38747600)
36. Anderson BE, McNiff JM, Jain D, Blazar BR, Shlomchik WD, Shlomchik MJ. Distinct roles for donor-and hostderived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ. Blood 2005;105:2227-2234. (Pubitemid 40731817)
37. Petnicki-Ocwieja T, Hrncir T, Liu YJ, et al. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci USA 2009;106:15813-15818.
38. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 2005;307:731-734. (Pubitemid 40194644)
39. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-962.
40. Penack O, Smith OM, Cunningham-Bussel A, et al. NOD2 regulates hematopoietic cell function during graft-versus-host disease. J Exp Med 2009;206:2101-2110.
41. Calcaterra C, Sfondrini L, Rossini A, et al. Critical role of TLR9 in acute graft-versus-host disease. J Immunol 2008;181:6132-6139.
42. Heimesaat MM, Nogai A, Bereswill S, et al. MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease. Gut 2010;59:1079-1087.
43. Imado T, Iwasaki T, Kitano S, et al. The protective role of host Toll-like receptor-4 in acute graft-versus-host disease. Transplantation 2010;90:1063-1070.
44. Morecki S, Slavin S. Immunoregulation of GVHD by triggering the innate immune system with CpG. Expert Rev Hematol 2009;2:443-453.
45. Lorenz E, Schwartz DA, Martin PJ, et al. Association of TLR4 mutations and the risk for acute GVHD after HLAmatched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2001;7:384-387. (Pubitemid 32799056)
46. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9:313-323.
47. Conroy ME, Walker WA. Intestinal immune health. Nestle Nutr Workshop Ser Pediatr Program 2008;62:111-121; discussion 121-125.
48. Feng T, Wang L, Schoeb TR, Elson CO, Cong Y. Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis. J Exp Med 2010;207:1321-1332.
49. Williams AM, Probert CS, Stepankova R, Tlaskalova-Hogenova H, Phillips A, Bland PW. Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse. Immunology 2006;119:470-478. (Pubitemid 44722209)
50. Yamanaka T, Helgeland L, Farstad IN, Fukushima H, Midtvedt T, Brandtzaeg P. Microbial colonization drives lymphocyte accumulation and differentiation in the follicleassociated epithelium of Peyer's patches. J Immunol 2003; 170:816-822. (Pubitemid 36070533)
51. Zhang Q, Li Q, Wang C, Li N, Li J. Redistribution of tight junction proteins during EPEC infection in vivo. Inflammation 2010 Dec 18. [Epub ahead of print]
52. Zhang Q, Li Q, Wang C, Liu X, Li N, Li J. Enteropathogenic Escherichia coli changes distribution of occludin and ZO-1 in tight junction membrane microdomains in vivo. Microb Pathog 2010;48:28-34.
53. Huelsenbeck SC, May M, Schmidt G, Genth H. Inhibition of cytokinesis by Clostridium difficile toxin B and cytotoxic necrotizing factors-reinforcing the critical role of RhoA in cytokinesis. Cell Motil Cytoskeleton 2009;66: 967-975.
54. Lima AA, Nascimento NR, Fang GD, et al. Role of phospholipase A2 and tyrosine kinase in Clostridium difficile toxin A-induced disruption of epithelial integrity, histologic inflammatory damage and intestinal secretion. J Appl Toxicol 2008;28:849-857.
55. Salzman NH, Hung K, Haribhai D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010;11:76-83.
56. Medini D, Serruto D, Parkhill J, et al. Microbiology in the post-genomic era. Nat Rev Microbiol 2008;6:419-430.
57. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006;312:1355-1359. (Pubitemid 43839542)
58. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The human microbiome project. Nature 2007;449:804-810. (Pubitemid 47598620)
59. Dethlefsen L, Huse S, SoginML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008;6:e280.
60. Antonopoulos DA, Huse SM, Morrison HG, Schmidt TM, Sogin ML, Young VB. Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun 2009;77:2367-2375.
61. Storb R, Prentice RL, Buckner CD, et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med 1983;308: 302-307. (Pubitemid 13179412)
62. Tilg H. Obesity, metabolic syndrome, and microbiota: multiple interactions. J Clin Gastroenterol 2010;44(Suppl. 1): S16-S18.
63. Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking Tolllike receptor 5. Science 2010;328:228-231.
64. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature 2009;457:480-484.
65. Wen L, Ley RE, Volchkov PY, et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008;455:1109-1113.
66. Zipris D. Toll-like receptors and type 1 diabetes. Adv Exp Med Biol 2010;654:585-610.
67. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol 2010;8:564-577.
68. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-1463. (Pubitemid 44871953)
69. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001; 357:1925-1928. (Pubitemid 32568333)
70. Spor A, Koren O, Ley R. Unravelling the effects of the environment and host genotype on the gut microbiome. Nat Rev Microbiol 2011;9:279-290.
71. Sellon RK, Tonkonogy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-5231. (Pubitemid 29044613)
72. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-261. (Pubitemid 23320289)
73. Garrett WS, Lord GM, Punit S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007;131:33-45. (Pubitemid 47505255)
74. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444: 1027-1031. (Pubitemid 46018515)
75. FrankDN, St Amand AL, Feldman RA, Boedeker EC,Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007;104:13780-13785. (Pubitemid 350003397)
76. Sokol H, Pigneur B, Watterlot L, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci USA 2008;105:16731-16736.
77. Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011;331:337-341.
78. Atarashi K, Nishimura J, Shima T, et al. ATP drives lamina propriaT(H)17 cell differentiation.Nature 2008;455:808-812.
79. Hall JA, Bouladoux N, Sun CM, et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008;29:637-649.
80. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008;453:620-625. (Pubitemid 351769307)
81. Round JL, Mazmanian SK. Inducible Foxp3p regulatory Tcell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci USA 2010;107:12204-12209.
82. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGFbeta-bearing regulatory cells. J Immunol 2005;174:3237-3246. (Pubitemid 40354026)
83. O'Mahony C, Scully P, O'Mahony D, et al. Commensalinduced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation. PLoS Pathog 2008;4:e1000112.
84. Foligne B, Zoumpopoulou G, Dewulf J, et al. A key role of dendritic cells in probiotic functionality. PLoS One 2007; 2:e313.
85. Peran L, Camuesco D, Comalada M, et al. A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis. J Appl Microbiol 2007;103:836-844. (Pubitemid 47493215)
86. Ma D, Forsythe P, Bienenstock J. Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun 2004; 72:5308-5314. (Pubitemid 39223418)
87. Schultz M, Veltkamp C, Dieleman LA. Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm Bowel Dis 2002;8:71-80. (Pubitemid 34213503)
88. Kelly D, Campbell JI, King TP, et al. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclearcytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol 2004;5:104-112. (Pubitemid 38081475)
89. Karrasch T, Kim JS, Muhlbauer M, Magness ST, Jobin C. Gnotobiotic IL-10-/-;NF-kappa B(EGFP) mice reveal the critical role of TLR/NF-kappa B signaling in commensal bacteria-induced colitis. J Immunol 2007;178:6522-6532. (Pubitemid 46717436)
90. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by tolllike receptors is required for intestinal homeostasis. Cell 2004;118:229-241. (Pubitemid 38962578)
91. Bauer C, Duewell P, Mayer C, et al. Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 2010;59:1192-1199.
92. McGuckin MA, Eri R, Simms LA, Florin TH, Radford-Smith G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis 2009;15:100-113.
93. McLaughlin MM, Dacquisto MP, Jacobus DP, Horowitz RE. Effects of the germfree state on responses to whole-body irradiation. Radiat Res 1964;23:333-349.
94. Garin-Laflam MP, Steinbrecher KA, Rudolph JA, Mao J, Cohen MB. Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis Am J Physiol Gastrointest Liver Physiol 2009;296:G740-G749.
95. Egan LJ, Eckmann L, Greten FR, et al. Ikappa B-kinase betadependent NF-kappaB activation provides radioprotection to the intestinal epithelium. Proc Natl Acad Sci USA 2004;101: 2452-2457. (Pubitemid 38269332)
96. Schneider MR, Dahlhoff M, Horst D, et al. A key role for Ecadherin in intestinal homeostasis and Paneth cell maturation. PLoS One 2010;5:e14325.
97. Boirivant M, Amendola A, Butera A, et al. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis. Gastroenterology 2008;135:1612-1623.e5.
98. Crawford PA, Gordon JI. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci USA 2005;102:13254-13259. (Pubitemid 41325010)
99. Bäckhed F, Manchester JK, Semenkovich CF, Gordon JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA 2007;104:979-984. (Pubitemid 46154722)
100. Fleissner CK, Huebel N, Abd El-Bary MM, Loh G, Klaus S, Blaut M. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr 2010;104: 919-929.
101. Fukuda S, Toh H, Hase K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011;469:543-547.
102. Hill GR, Crawford JM, Cooke KR, Brinson YS, Pan L, Ferrara JL. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997;90:3204-3213. (Pubitemid 27444217)
103. Cooke KR, Hill GR, Crawford JM, et al. Tumor necrosis factor-alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graftversus-host disease. J Clin Invest 1998;102:1882-1891. (Pubitemid 28533836)
104. Murai M, Yoneyama H, Ezaki T, et al. Peyer's patch is the essential site in initiating murine acute and lethal graftversus-host reaction. Nat Immunol 2003;4:154-160. (Pubitemid 36193017)
105. Holler E, Rogler G, Herfarth H, et al. Both donor and recipient NOD2/CARD15 mutations associate with transplantrelated mortality and GvHD following allogeneic stem cell transplantation. Blood 2004;104:889-894. (Pubitemid 38970589)
106. Elmaagacli AH, Koldehoff M, Hindahl H, et al. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graftversus-host disease in patients who underwent an allogeneic transplantation. Transplantation 2006;81:247-254.
107. Li H, Matte-Martone C, Tan HS, et al. Graft-versus-host disease is independent of innate signaling pathways triggered by pathogens in host hematopoietic cells. J Immunol 2011; 186:230-241.
108. Gerbitz A, Schultz M, Wilke A, et al. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 2004;103:4365-4367. (Pubitemid 38685386)
109. Cooke KR, Gerbitz A, Crawford JM, et al. LPS antagonism reduces graft-versus-host disease and preserves graft-versusleukemia activity after experimental bone marrow transplantation. J Clin Invest 2001;107:1581-1589. (Pubitemid 32574644)
110. Chakraverty R, Côté D, Buchli J, et al. An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues J Exp Med 2006;203:2021-2031. (Pubitemid 44188475)
111. Taylor PA, Ehrhardt MJ, Lees CJ, et al. TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection. Blood 2008;112: 3508-3516.
112. Jasperson LK, Bucher C, Panoskaltsis-Mortari A, Mellor AL, Munn DH, Blazar BR. Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality. Blood 2009;114:5062-5070.
113. Morecki S, Yacovlev E, Gelfand Y, Shabat Y, Slavin S. Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators. Biol Blood Marrow Transplant 2009;15:406-415.
114. Holler E, Rogler G, Brenmoehl J, et al. Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 2006;107:4189-4193. (Pubitemid 43726832)
115. van der Velden WJ, Blijlevens NM, Maas FM, et al. NOD2 polymorphisms predict severe acute graft-versus-host and treatment-related mortality in T-cell-depleted haematopoietic stem cell transplantation. Bone Marrow Transplant 2009;44:243-248.
116. Granell M, Urbano-Ispizua A, Aró stegui JI, et al. Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation. Haematologica 2006;91:1372-1376. (Pubitemid 44569811)
117. Sairafi D, Uzunel M, Remberger M, Ringdén O, Mattsson J. No impact of NOD2/CARD15 on outcome after SCT. Bone Marrow Transplant 2008;41:961-964. (Pubitemid 351850500)
118. Mayor NP, Shaw BE, Hughes DA, et al. Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. J Clin Oncol 2007;25:4262-4269. (Pubitemid 47548566)
119. Gruhn B, Intek J, Pfaffendorf N, et al. Polymorphism of interleukin-23 receptor gene but not of NOD2/CARD15 is associated with graft-versus-host disease after hematopoietic stem cell transplantation in children. Biol Blood Marrow Transplant 2009;15:1571-1577.